PegBio Co., Ltd. (HKG:2565)
Hong Kong · Delayed Price · Currency is HKD 60.70
-1.30 (-2.10%)
Last updated: Mar 6, 2026, 3:30 PM HKT
PegBio Market Cap
PegBio has a market cap or net worth of 24.25 billion as of March 6, 2026.
Market Cap
24.25B
Enterprise Value
23.98B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
60.70
Market Cap Chart
Since May 27, 2025, PegBio's market cap has increased from 4.46B to 24.25B, an increase of 443.47%. That is a compound annual growth rate of 794.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 24.25B | -10.14% |
| Dec 31, 2025 | 26.99B | 504.83% |
| May 27, 2025 | 4.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Henlius Biotech | 35.19B |
| Biocytogen Pharmaceuticals (Beijing) | 32.10B |
| Shanghai Junshi Biosciences | 30.65B |
| Duality Biotherapeutics | 26.25B |
| TransThera Sciences (Nanjing) | 25.58B |
| Genscript Biotech | 23.79B |
| InnoCare Pharma | 22.64B |
| Zai Lab | 16.88B |